Browsing: Gastrointestinal

Top Line: Does adjuvant chemoradiation still have a role for resected pancreatic adenocarcinoma?The Study: NRG/RTOG 0848 randomized 354 patients with…

DIPLOMA-2 reports patients undergoing minimally invasive versus open pancreatoduodenectomy achieve faster recovery—novely captured by donning a Fitbit activity tracker for…

This review summarizes everything you never knew you needed to know about Barret’s esophagus including aggressive PPI (i.e. high-dose esomeprazole…

A French population-based cohort spanning 2004–2021 zooms in on metastatic patterns in colorectal adenocarcinoma revealing a sharp relative risk in…

This practical contouring guide walks through modern target delineation for a cT3N1 mid-rectal cancer undergoing long-course chemoradiation. Gone are the…

Adjuvant nivolumab improves DFS in patients with resected esophageal cancer following neoadjuvant chemoradiation. In this phase 2 trial, 35 patients…

Top Line: When adding a PD-1 inhibitor onto definitive chemoradiation for unresectable locally advanced esophageal squamous cell carcinoma (ESCC), does…

Top Line: When it comes to definitive radiation for pancreatic cancer, dose escalation may win the battle, while volume expansion…

Here is another sweeping review to walk us through the evolution from upfront total mesorectal excision ± radiation to modern…

Top Line: The management of locally advanced rectal cancer has become extremely nuanced over the past few years.The Study: Here…